NeuroResponse

London, United Kingdom

NeuroResponse is a healthcare company that provides patients with Multiple Sclerosis necessary access to clinicians to obtain medications.

$1.3M raised

Dec 2021

Grant

Health Care Health Diagnostics Medical Personal Health

Top Investors

SBRI Healthcare

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NeuroResponse

How much funding has NeuroResponse raised?

NeuroResponse has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in December 2021.

Who are NeuroResponse's investors?

NeuroResponse's investors include SBRI Healthcare.

Where is NeuroResponse headquartered?

NeuroResponse is headquartered in London, United Kingdom.

What does NeuroResponse do?

NeuroResponse is a healthcare company that provides patients with Multiple Sclerosis necessary access to clinicians to obtain medications.

What stage is NeuroResponse at?

NeuroResponse is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 20, 2021.

MLA

"NeuroResponse — Funding & Investors." VCBacked, December 20, 2021, https://www.vcbacked.co/company/neuroresponse. Accessed July 2, 2026.

APA

VCBacked. (2021). NeuroResponse — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neuroresponse

Wikipedia (cite web)

{{cite web |title=NeuroResponse — Funding & Investors |url=https://www.vcbacked.co/company/neuroresponse |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 20, 2021.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K